Skip to main content
Top

Cancer Causes & Control

Issue 1/2004

Content (16 Articles)

Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA)

James R. Cerhan, Dawn M. Grabrick, Robert A. Vierkant, Carol A. Janney, Celine M. Vachon, Janet E. Olson, Larry H. Kushi, Thomas A. Sellers

Foods, nutrients and prostate cancer

Allison M. Hodge, Dallas R. English, Margaret R.E. McCredie, Gianluca Severi, Peter Boyle, John L. Hopper, Graham G. Giles

Subjective and objective risk of colorectal cancer (UK)

Kathryn A. Robb, Anne Miles, Jane Wardle

Adolescent smoking and trends in lung cancer incidence among young adults in Norway 1954–1998

Trond-Eirik Strand, Columbo Malayeri, Petri K.J. Eskonsipo, Tom K. Grimsrud, Jarle Norstein, Tom Grotmol

Obesity and cancer risk among white and black United States veterans

Claudine Samanic, Gloria Gridley, Wong-Ho Chow, Jay Lubin, Robert N. Hoover, Joseph F. Fraumeni Jr.

Serum levels of sex hormones and breast cancer risk in premenopausal women: a case–control study (USA)

Susan R. Sturgeon, Nancy Potischman, Kathleen E. Malone, Joanne F. Dorgan, Janet Daling, Cathy Schairer, Louise A. Brinton

Flavonoids, vitamin C and adenocarcinoma of the stomach

P. Lagiou, E. Samoli, A. Lagiou, J. Peterson, A. Tzonou, J. Dwyer, D. Trichopoulos

Adolescent diet and risk of breast cancer

A. Lindsay Frazier, Lisa Li, Eunyong Cho, Walter C. Willett, Graham A. Colditz

Sedentary behaviours and epithelial ovarian cancer risk

Min Zhang, Xing Xie, Andy H. Lee, Colin W. Binns

Letter to the Editor

Trends in the incidence of ocular melanoma in the United States, 1974–1998

Andreas Stang, Karl-Heinz Jöckel

Letter to the Editor

No evidence for reduced 25-hydroxyvitamin D serum levels in melanoma patients

Jörg Reichrath, Kerstin Querings

Letter to the Editor

Processed meat consumption and adult gliomas in a Maryland cohort

Dana E.M. Rollison, Kathy J. Helzlsouer

The Authors Reply

Peter D. Inskip, Susan S. Devesa, Joseph F. Fraumeni Jr.

Corrigendum

Corrigendum

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine